Combined phaco-vitrectomy provides lower costs and greater area under the curve vision gains than sequential vitrectomy and phacoemulsification
- PMID: 32813107
- DOI: 10.1007/s00417-020-04877-4
Combined phaco-vitrectomy provides lower costs and greater area under the curve vision gains than sequential vitrectomy and phacoemulsification
Abstract
Purpose: A majority of phakic patients undergoing pars plana vitrectomy for epiretinal membrane or macular hole require subsequent cataract surgery within 1-2 years. Combined phaco-vitrectomy eliminates the need for a second surgery and may enable patients to attain their best vision sooner. This study aims to compare the visual outcomes, complication rates, and costs of combined phaco-vitrectomy versus sequential vitrectomy followed by cataract surgery.
Methods: Records were searched by CPT® codes to identify patients with both cataract and vitrectomy surgery at our institution over a 5-year period (2013-2018). Chart review included medical history, demographics, exam findings, operating room records, visual acuity (VA), and clinical outcomes. Statistical analyses were performed with SPSS v19 (IBM). Area under the curve for visual acuity was calculated as the trapezoidal mean of the change in Early Treatment of Diabetic Retinopathy Study letters.
Results: After exclusion, 81 eyes of 78 patients underwent both cataract and vitrectomy surgeries at our institution. Thirty-four eyes underwent separate, sequential vitrectomy then phacoemulsification surgery, and 47 eyes had combined phaco-vitrectomy surgery. Total operating room times (120.81 ± 3.41 vs 161.03 ± 5.45 min; p < 0.0001) and associated costs were significantly lower in the combined surgery compared with those in the sequential surgery group. Baseline and final visual acuity were similar between the two groups. Baseline VA was 35.53 letters (~ 20/200) and 32.81 letters (~ 20/220) and increased to final VA of 63.74 (~ 20/53) and 60.91 letters (~ 20/61), in the sequential and combined groups respectively. Area under the curve for vision was greater in the combined surgery group, with subjects gaining an average of + 9.11 ± 3.32 letters from sequential surgery, and + 19.53 ± 3.53 letters in the combined surgery group (p = 0.04). Additionally, patients in the combined group attained their best visual acuity 449 days (15 months) sooner than those receiving sequential surgery.
Conclusions: Combined phaco-vitrectomy surgery resulted in greater area under the curve visual acuity benefit and attainment of best visual acuity 15 months sooner compared with conventional sequential surgeries. There were no significant differences in complication rates or clinical outcomes between the groups, but operative times and costs were lower for combined surgery, supporting a favorable cost-benefit ratio. Graphical abstract.
Keywords: Area under the curve vision; Combined phaco-vitrectomy; Cost analysis; Pars plana vitrectomy; Phacoemulsification.
References
-
- Cheng L, Azen SP, El-Bradey MH et al (2001) Duration of vitrectomy and postoperative cataract in the vitrectomy for macular hole study. Am J Ophthalmol 132:881–887 - DOI
-
- Jackson TL, Donachie PHJ, Williamson TH et al (2015) The Royal College Of Ophthalmologists’ national ophthalmology database study of vitreoretinal surgery: report 4, epiretinal membrane. Retina Phila Pa 35:1615–1621. https://doi.org/10.1097/IAE.0000000000000523 - DOI
-
- Jackson TL, Donachie PHJ, Sparrow JM, Johnston RL (2013) United Kingdom National Ophthalmology Database study of vitreoretinal surgery: report 2, macular hole. Ophthalmology 120:629–634. https://doi.org/10.1016/j.ophtha.2012.09.003 - DOI - PubMed
-
- Mompremier M, Adyanthaya R Retina today - phacovitrectomy for the retina surgeon. In: Retina Today http://retinatoday.com/2014/10/phacovitrectomy-for-the-retina-surgeon/ . Accessed 14 May 2019
-
- Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross JG, Glassman AR et al (2015) Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA 314:2137–2146. https://doi.org/10.1001/jama.2015.15217 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
